The pathogenesis of psoriasis appears to depend on T cells, which have been proposed to mediate the disease through an autoimmune process. To test this hypothesis we have propagated four T-cell lines from biopsies of psoriatic skin lesions by antigen-independent methods. Flow cytometric immunophenotyping showed the lines to be composed mainly of CD4-positive, αβ-cell receptor (TCR)-positive cells, which secreted a cytokine profile suggestive of predominant T-helper type 1 (Th1) status. Analysis of TCR variable region (Vβ) usage revealed two- to eight-fold increases in the expression of certain Vβ species in lesional lines as compared with autologous peripheral blood mononuclear cells (PBMC), with the increased Vβ species being expressed on more than 5% of cells in two of the lines. Lines were also used to test for responses to a range of epidermal antigen preparations in the presence of irradiated autologous PBMC as antigen-presenting cells. The lines failed to proliferate in response to psoriatic lesional stratum corneum extracts, dispase-separated normal human epidermal extracts, and an epidermal keratin preparation before and after trypsinization, in spite of good proliferative responses to anti-CD3 which indicated that the lines were not anergic. In addition, the lines and PBMC from normal volunteers and the patients with psoriasis gave little or no response to recombinant streptococcal M protein. Thus, in spite of accumulating evidence for selective expansion of certain Vβ-expressing T cells in psoriatic lesions, epidermal autoantigens have not been identified by using a bioassay which depended largely on the proliferation of lesional CD4-positive cells. The role of streptococcal M protein, which bears some homology with epidermal keratin is also open to question, at least in chronic plaque psoriasis. Further work is therefore required to obtain direct evidence that autoimmune processes are important in the pathogenesis of chronic plaque psoriasis.

References

1 Elder JT, Nair RP, Guo S-W et al. The genetics of psoriasis. Arch Dermatol 1994; 216: 224 – 9.
Google Scholar
2 Ragaz A, Ackerman AB. Evolution, maturation and regression of lesions of psoriasis. Am J Dermatolpathol 1979; 1: 199 – 214.
10.1097/00000372-197900130-00002
PubMed Google Scholar
3 Bos JD, Hulsebosch HJ, Krieg SR. Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res 1983; 275: 181 – 9.
10.1007/BF00510050
PubMed Web of Science® Google Scholar
4 Baker BS, Swain AF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110: 555 – 64.
10.1111/j.1365-2133.1984.tb04678.x
CAS PubMed Web of Science® Google Scholar
5 Ramirez-Bosca A, Martinez-Ojeda L, Valcuende-Cavero F, Castells-Rodellas A. A study of local immunity in psoriasis. Br J Dermatol 1988; 119: 587 – 95.
10.1111/j.1365-2133.1988.tb03469.x
PubMed Web of Science® Google Scholar
6 Horrocks C, Duncan JI, Ormerod AD, Thomson AW. The effects of systemic cyclosporin A on the expression of interleukin 2 and epidermal growth factor receptors in psoriatic lesions. Clin Exp Immunol 1989; 78: 166 – 71.
PubMed Web of Science® Google Scholar
7 Markey AC, Allen MH, Pitzalis C, MacDonald DM. T-cell inducer populations in cutaneous inflammation: a predominance of T helper-inducer lymphocytes (THi) in the infiltrate of inflammatory dermatoses. Br J Dermatol 1990; 122: 325 – 32.
10.1111/j.1365-2133.1990.tb08280.x
PubMed Web of Science® Google Scholar
8 van Joost T, Bos JD, Heule F, Meinardi MMHM. Low-dose cyclosporin A in severe psoriasis. A double-blind study. Br J Dermatol 1988; 118: 183 – 90.
10.1111/j.1365-2133.1988.tb01772.x
CAS PubMed Web of Science® Google Scholar
9 Ellis CN, Fradin MS, Messana JM et al. Cyclosporin for plaque-type psoriasis. Results of a multi-dose, double-blind trail. N Engl J Med 1991; 324: 277 – 84.
10.1056/NEJM199101313240501
CAS PubMed Web of Science® Google Scholar
10 Jegasothy BV, Ackerman CD, Todo S et al. Tacrolimus (FK506)-a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1992; 128: 781 – 5.
PubMed Web of Science® Google Scholar
11 Nicolas J-F, Chamchick N, Thivolet J et al. CD4 antibody treatment of severe psoriasis. Lancet 1991; 338: 321.
10.1016/0140-6736(91)90465-2
CAS PubMed Web of Science® Google Scholar
12 Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB₃₈₉IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1995; 1: 442 – 7.
10.1038/nm0595-442
CAS PubMed Web of Science® Google Scholar
13 Kapp A, Piskorski A, Schopf E. Elevated levels of interleukin 2 receptor in sera of patients with psoriasis and atopic dermatitis. Br J Dermatol 1988; 119: 707 – 10.
10.1111/j.1365-2133.1988.tb03491.x
PubMed Web of Science® Google Scholar
14 Morganroth GS, Chan LS, Weinstein GD et al. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa⁺ perivascular dendritic cells. J Invest Dermatol 1991; 96: 333 – 40.
10.1111/1523-1747.ep12465237
PubMed Web of Science® Google Scholar
15 Stange P, Cooper KD, Hansen ER et al. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993; 101: 695 – 700.
10.1111/1523-1747.ep12371678
CAS PubMed Web of Science® Google Scholar
16 Lewis HM, Baker BS, Bokth S et al. Restricted cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993; 129: 514 – 20.
10.1111/j.1365-2133.1993.tb00477.x
PubMed Web of Science® Google Scholar
17 Chang JCC, Smith LR, Froning KJ et al. CD8⁺ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282 – 6.
10.1073/pnas.91.20.9282
CAS PubMed Web of Science® Google Scholar
18 Leung DYM, Travers JB, Giorno R et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106 – 12.
10.1172/JCI118263
CAS PubMed Web of Science® Google Scholar
19 Menssen A, Trommler P, Vollmer S et al. Evidence for an antigenspecific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1995; 155: 4078 – 83.
CAS PubMed Web of Science® Google Scholar
20 Valdimarsson H, Baker BS, Jansdottir I, Fry L. Psoriasis: a disease of keratinocyte proliferation induced by T-lymphocytes. Immunol Today 1986; 7: 256 – 9.
10.1016/0167-5699(86)90005-8
CAS PubMed Web of Science® Google Scholar
21 Aoki S, Yaoita H, Kitajima Y. An elevated level of autoantibodies against 48- to 50-kd keratins in the serum of patients with psoriasis. J Invest Dermatol 1989; 92: 179 – 83.
10.1111/1523-1747.ep12276700
CAS PubMed Web of Science® Google Scholar
22 Camp RDR. Psoriasis. In: Textbook of Dermatology ( RH Champion, JL Burton, FJG Ebling, eds). Oxford : Blackwell Scientific Publications. 1992; 1391 – 457.
Google Scholar
23 Fischetti VA. Streptococcal M protein: molecular design and biological behaviour. Clin Microbiol Rev 1989; 2: 285 – 314.
10.1128/CMR.2.3.285
CAS PubMed Web of Science® Google Scholar
24 Londei M, Grubeck B, De Beradinis P et al. Efficient propagation of human T-cells in the absence of antigen by means of OKT3, IL2 and antigen presenting cells. Scand J Immunol 1988; 27: 35 – 46.
10.1111/j.1365-3083.1988.tb02321.x
CAS PubMed Web of Science® Google Scholar
25 Hintner H, Neises GR, Lawley TJ. Immunologic properties of enzymatically degraded human keratin intermediate filaments. J Invest Dermatol 1985; 84: 108 – 13.
10.1111/1523-1747.ep12275037
CAS PubMed Web of Science® Google Scholar
26 Baker BS, Bokth S, Powles A et al. Group A streptococcal antigenspecific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128: 493 – 9.
10.1111/j.1365-2133.1993.tb00224.x
PubMed Web of Science® Google Scholar
27 Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterised by a T-helper type 1 cell-mediated resonse. J Invest Dermatol 1993; 101: 701 – 5.
10.1111/1523-1747.ep12371679
CAS PubMed Web of Science® Google Scholar
28 Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis belong to the Th1 subset. J Invest Dermatol 1994; 102: 145 – 9.
10.1111/1523-1747.ep12371752
PubMed Web of Science® Google Scholar
29 Prinz JC, Grob B, Vollmer S et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 1994; 24: 593 – 8.
10.1002/eji.1830240315
CAS PubMed Web of Science® Google Scholar
30 Hales JM, Camp RDR. Normal human stratum corneum contains at least four T cell stimulatory components with antigenic properties. J Invest Dermatol 1996; 107: 496(Abstr.).
Google Scholar
31 Bour H, Nicolas J-F, Schmitt D et al. Oligoclonal T cell response in psoriatic cutaneous lesions. J Invest Dermatol 1994; 103: 453 (Abstr.).
Web of Science® Google Scholar

Citing Literature

Volume137, Issue3

September 1997

Pages 331-338

Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity

Summary

References

Citing Literature

References

Related

Information